09.00–09.10 Welcoming address: prof. V. Ostapenko, President of Lithuanian Senological Society.
09.10–09.25 „And Life Goes On…” A. Bružienė, President of National Association of Breast Disease, Vilnius, Lithuania.
09.25–09.45 Epidemiology of Breast Cancer in Lithuania. Prof. G. Smailytė, National Cancer Institute, Vilnius, Lithuania.
09.50–10.05 Hereditary breast cancer syndrome: multigene testing and cancer risk management. O. Liaugaudienė, MD, National Cancer Institute, Vilnius, Lithuania.
10.10–10.25 Triple negative breast carcinoma: low grade spectrum. G. Liubertaitė, MD, B. Valkiūnienė, MD, State Pathology Center, Vilnius, Lithuania
10.25–10.45 Coffee break
10.45–11.00 Radiogenomics in breast cancer diagnosis. Dr. R. Briedienė, Dr. J. Ušinskienė, National Cancer Institute, Vilnius, Lithuania
11.05–11.20 Neoadjuvant Radiotherapy in Breast Cancer. Dr. E. Korobeinikova, Lithuanian University of Health Sciences, Kaunas, Lithuania
11.25–11.40 New Modalities in Breast Cancer Radiotherapy. Dr. A. Burneckis, National Cancer Institute, Vilnius, Lithuania
11.45–12.00 Psychosocial rehabilitation of the women with breast cancer. Dr. G. Bulotienė, G. Dylertaitė, MD, National Cancer Institute, Vilnius, Lithuania
12:05–12.15 Benefits of Prognostic Breat Cancer Testing: Technology and Case Studies“. Dr. Bertrand Farnault (Marseille, France).
12.20–12.40 Coffee break
12.45–13.15 Safety of autologous fat grafting in breast cancer: a multicenter Italian study. A. Lisa, MD, European Institute of Oncology, Milan, Italy.
13.15–13.45 Early complications after immediate implant-based breast reconstruction. Prof. V. Ostapenko, National Cancer Institute; Kardiolitos Klinikos, Vilnius, Lithuania.
13.50–14.20 Robotic Breast Surgery: questions and reflections. Dr. N. Peradze, European Institute of Oncology, Milan, Italy.
14.25–14.40 Immediate prepectoral implant-based breast reconstruction. A new standard? E. Ostapenko, MD, Vilnius University, Vilnius, Lithuania.
14.45–15.15 Conservative implant-based breast reconstruction. Prof. F. De Lorenzi, European Institute of Oncology, Milan, Italy.
15.20–15.45 Treatment of HER2-positive breast cancer:current status and
future perspective. Prof. T*.*Pienkowski, Warsaw, Poland.
15.50–16.10 Coffee Break
16.50–17.05 Axillary surgery vs SLNB in triple negative breast cancer. St. Gallen consensus 2023 and short panelists of the St. Gallen Consensus
17.45–18.15 St. Gallen
18.20–18.35 Closing remarks. P